Last updated:
Psilocybe Tampanensis
"Tampa Psilocybe"
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeTampanensis-1_new-800x450.webp)
Scientific Classification
About
Psilocybe tampanensis, commonly known as the Tampa Psilocybe, is a rare psychedelic mushroom most notable for producing dense underground sclerotia, often referred to as “magic truffles” or “philosopher’s stones.” Native to Florida, USA (where it was first discovered), and parts of Mexico, it contains the psychoactive compounds psilocybin and psilocin, which induce altered states of consciousness, enhanced introspection, and visual hallucinations.
History
First discovered in 1977 near Tampa, Florida, by mycologists Steven Pollock and Gary Lincoff, only one wild specimen was ever found in that region. Fortunately, the strain was cloned and preserved, allowing for widespread cultivation. It later appeared in the wild in Mexico, expanding its known range.
Due to the difficulty of finding mature fruiting bodies in nature, the species is more often cultivated for its sclerotia, which grow underground and are legal to possess in some countries. P. tampanensis played an influential role in the early study of entheogenic fungi and remains popular in psychonaut and microdosing communities.
Overview
The mushroom produces small, caramel to yellow-brown caps (up to 2 cm wide) with a slender, curved stem. The fruiting bodies bruise blue when handled, a sign of psilocybin presence. However, its underground sclerotia are the primary product of interest—dense, nut-like growths that form from the mycelium and contain psychoactive compounds.
The sclerotia are consumed fresh or dried and are valued for producing more subtle and introspective psychedelic experiences than the mushroom caps. They are often used in spiritual settings, self-exploration, or personal therapy. While not generally eaten for flavor or nutrition, they are rich in psilocybin, a compound under study for treating depression, PTSD, and anxiety.
Physical Characteristics
Caps:
Convex to broadly convex, sometimes with a low umbo, 2-5 cm wide, reddish-brown to yellowish-brown, fading to pale ochre when dry
Gills:
Adnate to adnexed, initially pale, becoming purplish-black with age
Psychoactive Effects
Euphoric
Describing intense feelings of happiness or excitement
Perceptual
The change in the way things are perceived, including changes in time perception, spatial perception, and perception of one's own body.
Pharmacology
Helps With
Depression
Relieves symptoms of depression, improving mood and outlook
Anxiety
Helps to alleviate feelings of worry, fear, and unease
Addiction
Helps to overcome addiction and substance abuse
PTSD
Helps to alleviate symptoms of post-traumatic stress disorder
OCD
Helps to alleviate symptoms of obsessive-compulsive disorder
ADD ADHD
Helps to alleviate symptoms of attention deficit disorder and attention deficit hyperactivity disorder
Pain
Microdosing psilocybin has been shown to help with certain types of pain
Migraines
Research shows that psilocybin, the active compound in magic mushrooms, has potential therapeutic benefits for migraines. A small-scale study conducted by Yale School of Medicine found that a single dose of psilocybin reduced the likelihood of having a migraine attack in two weeks.
Possible Side Effects
Nausea
A feeling of discomfort in the stomach with an urge to vomit
Grow at Home
Start your cultivation journey with quality grow kits from verified vendors
Chemical Constituents
Medicinal Chemistry
Similar Species
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeSubcubensis_new-400x400.webp)
Species: Psilocybe cubensis
Edibility: Psychoactive
Key Differences: P. cubensis typically has a more golden cap color and a more slender stem compared to P. tampanensis.
![[object Object]](https://d16q8n2b2c01ef.cloudfront.net/media/PsilocybeSubcubensis_new-400x400.webp)
Species: Psilocybe cubensis
Edibility: Psychoactive
Mushroom Ratings
0.0
Based on 0 Reviews
5
★4
★3
★2
★1
★Share your thoughts
If you've consumed this mushroom, share your thoughts with our community
References
- Sekssaoui, M. (2024). Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?. .
- Ley, L. (2023). Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. .
- Bae, S. (2023). Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis. .
- Schindler, E. (2022 ). Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial. .
- Barrett, F. (2022). Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation. .
- Desai, S. (2022). Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study. .
- Rucker, J. (2021). Psilocybin: From Serendipity to Credibility?. .
- Schindler, E. (2021). Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin. .
- Raval, N. (2021). A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. .
- Kuypers, K. (2019). Psychedelic medicine: The biology underlying the persisting psychedelic effects. .